company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9891000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9891000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4665000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2168000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3087000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6145000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6145000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2986000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-350000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2097000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3884000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1549000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1549000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-9841000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,235000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9606000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9606000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,951000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16349000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49120000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49120000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4144000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,359000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,44490000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4074000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3947000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3947000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3363000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1328000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-822000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4400000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1113000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1113000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,162000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3012000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,292000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,554000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4397000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5417000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7734000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10221000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10221000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2784000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-820000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2716000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-915000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-915000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5742000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,20000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,294000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5428000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5428000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,329000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16235000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4430000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6608000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4011000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6459000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6459000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3056000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-167000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-527000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9056000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5306000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5306000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,2174000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-20000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-147000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2096000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2096000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,133000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13994000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5852000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5852000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4617000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2826000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6970000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5379000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5379000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2052000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-117000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2676000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-401000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,288000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-113000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-113000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1016000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6008000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4526000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19475000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8068000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7660000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7660000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2945000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-112000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,537000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1596000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-924000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-924000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3401000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-123000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3524000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3524000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-726000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2486000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,910000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3807000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3807000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4535000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1068000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7476000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5680000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5680000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2155000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-131000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,50000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,213000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2023000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2023000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4906000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,233000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4673000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4673000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,636000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11740000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,257000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,257000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4365000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3815000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2864000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5573000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5573000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2242000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-186000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2428000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2428000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2931000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,108000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2177000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2177000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-171000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5151000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2143000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2143000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4158000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1618000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4135000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4532000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4532000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2728000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-131000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,397000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2462000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2462000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,190000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,189000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,189000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,19000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2278000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1432000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1432000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4274000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7330000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2124000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10912000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10912000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2765000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-104000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2869000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2869000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-227000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-227000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-227000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-196000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7620000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,463000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,759000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6505000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6505000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-4117000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5230000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-486000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7132000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7132000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2446000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-116000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2562000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2562000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-151000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,629000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,352000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,831000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,829000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-157000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5242000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2247000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2247000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12250000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3207000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5570000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12366000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12366000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2416000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-169000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,169000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2416000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2416000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-265000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-91000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,344000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,233000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,276000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,497000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,499000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1018000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9431000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3930000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3930000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3818000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1267000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4854000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4161000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4161000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2792000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-31000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2823000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2823000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-66000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,643000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,64000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-225000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1754000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3580000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3580000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3614000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,837000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,923000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4437000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4517000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4517000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3481000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-95000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,131000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3445000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3445000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4870000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,150178000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23122000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-33507000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,134916000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,134916000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,220000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,136208000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1251000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3398000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3761000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1695000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1783000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15246000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8073000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8073000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2952000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-102000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3054000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3054000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-334000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-314000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1344000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,635000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1510000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1510000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,312000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9305000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3724000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3724000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4264000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2161000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6234000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3945000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12438000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12438000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3494000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-38800000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-42294000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-42294000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6819000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-108000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,175000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,445000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6486000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6486000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,136000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36206000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5041000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1700000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3457000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2008000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-451000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-451000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5567000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-107193000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,80000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-112680000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-112680000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,935000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-119000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,616000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,376000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1808000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1808000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-678000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-112001000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1861000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1861000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5287000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1746000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4827000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12008000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2009000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2009000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5176000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-55000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5231000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5231000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,611000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-38000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,35472000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,178000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,186000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,36409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,36409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-590000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28579000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3536000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5928000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2223000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2223000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5486000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1780000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1383000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2055000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4371000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4371000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4127000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-59371000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,31000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-63467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-63467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-477000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,39400000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1038000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1153000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41080000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41080000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-464000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18480000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,110000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,195000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2307000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2307000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6276000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1811000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3745000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1502000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3414000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-339000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3753000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3753000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-342000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-140000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,652000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1049000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,563000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1782000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1782000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,371000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14041000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2206000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,81000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4170000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4170000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6908000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2536000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3751000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9458000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18483000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18483000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6118000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-86000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-92118000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-92118000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-76423000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-162000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,198037000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,731000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-9990000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,112193000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,112193000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1652000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36906000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,803000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1297000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1785000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1785000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8379000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2907000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-686000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11252000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1133000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1133000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8382000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-53996000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-62378000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-62378000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13274000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-45000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,32658000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,640000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10382000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30361000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30361000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,765000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30119000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,8455000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6631000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10067000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10067000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8524000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2783000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2840000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7618000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11698000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11698000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11629000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-103000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,13000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11719000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11719000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5839000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,620000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5933000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5933000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,804000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5150000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3526000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:43:16+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,226000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21268000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21268000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7756000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2804000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2401000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11850000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3543000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3543000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13337000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1111000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,662000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13786000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13786000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4934000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-56000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2503000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,283000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2204000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2204000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1071000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13518000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5077000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15011000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5247000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4420000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11266000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10013000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10013000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12986000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-143299000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,13000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-156272000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-156272000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-61079000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-72000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,248603000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,925000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8230000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,180147000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,180147000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,219000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14081000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4119000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3150000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15411000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15411000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19313000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4980000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5058000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21407000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21407000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13476000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,2056000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11420000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11420000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-39219000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-132000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29760000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,196000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8230000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1165000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1165000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1578000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7244000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,8634000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4007000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10692000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10692000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16857000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5063000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1176000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18814000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6410000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6410000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3949000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-113000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4062000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4062000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34052000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1883000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,28066000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,632000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7237000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7237000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,902000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16807000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,7288000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 21:43:16+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,892000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10245000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10245000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17361000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5236000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8005000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5427000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14930000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14930000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6537000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-38000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6575000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6575000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-29350000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-68000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,24481000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,289000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4648000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4648000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3327000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7034000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,8190000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4082000.0
